This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Obstructive Sleep Apnea
and you are
between 30 and 60
years old
4
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

The purpose of this study is to determine the effects of the anticholinesterase drug donepezil on sleep apnea patients. Sleep structure and respiratory parameters will be analyzed by polysomnography.

Provided treatments

  • Drug: donepezil
  • Drug: placebo
Tris trial is registered with FDA with number: NCT00912457. The sponsor of the trial is Associacao Fundo de Incentivo a Psicofarmcologia and it is looking for 60 volunteers for the current phase.
Official trial title:
Donepezil Treatment for Sleep Apnea Patients: A Double Blind Placebo-Controlled Study